TRACON Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCON and other ETFs, options, and stocks.

About TCON

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma.

CEO

Charles P. Theuer

CEOCharles P. Theuer

Employees

Employees19

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2004

Founded2004

Employees

Employees19

TCON Key Statistics

Market cap

37.32M

Market cap37.32M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

64.97K

Average volume64.97K

High today

—

High today—

Low today

—

Low today—

Open price

$1.68

Open price$1.68

Volume

0.00

Volume0.00

52 Week high

$3.00

52 Week high$3.00

52 Week low

$1.10

52 Week low$1.10

TCON Earnings

-$0.58

-$0.39

-$0.19

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 14, After Hours

ActualExpected Mar 14, After Hours